▶ 調査レポート

急性期病院医療のグローバル市場(~2027):救急外科、救急医療、短期安定化、トラウマケア

• 英文タイトル:Acute Hospital Care Market Research Report by Medical Condition, Facility Type, Service, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Acute Hospital Care Market Research Report by Medical Condition, Facility Type, Service, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「急性期病院医療のグローバル市場(~2027):救急外科、救急医療、短期安定化、トラウマケア」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2303F0140
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、230ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査資料は、2021年に2,464.7億ドルであった世界の急性期病院医療市場規模が、2022年に2,657.4億ドルになり、2027年まで年平均7.99%で成長して3,910.5億ドルに到達すると予想しています。本調査資料では、急性期病院医療の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、病状別(救急外科、救急医療、短期安定化、トラウマケア)分析、施設種類別(一般急性期病院、長期急性期医療、精神科病院、リハビリテーション病院、専門病院)分析、サービス別(冠動脈ケアユニット、集中治療室、新生児集中治療室)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などを以下の構成でまとめております。さらに、市場参入企業として、3M Company、Asklepios Kliniken GmbH & Co. KGaA、bioMérieux SA、CareCentrix, Inc.、Community Health Systems, Inc.、Emerus Holdings, Inc.、Ernest Health, Inc.、Fresenius Medical Care AG & Co、HCA Healthcare, Inc.、IHH Healthcare Berhad、Legacy Lifepoint Health, Inc.、McKesson Corporation、Mediclinic International PLCなどの情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の急性期病院医療市場規模:病状別
- 救急外科の市場規模
- 救急医療の市場規模
- 短期安定化の市場規模
- トラウマケアの市場規模
・世界の急性期病院医療市場規模:施設種類別
- 一般急性期病院の市場規模
- 長期急性期医療の市場規模
- 精神科病院の市場規模
- リハビリテーション病院の市場規模
- 専門病院の市場規模
・世界の急性期病院医療市場規模:サービス別
- 冠動脈ケアユニットの市場規模
- 集中治療室の市場規模
- 新生児集中治療室の市場規模
・世界の急性期病院医療市場規模:地域別
- 南北アメリカの急性期病院医療市場規模
アメリカの急性期病院医療市場規模
カナダの急性期病院医療市場規模
ブラジルの急性期病院医療市場規模
...
- アジア太平洋の急性期病院医療市場規模
日本の急性期病院医療市場規模
中国の急性期病院医療市場規模
インドの急性期病院医療市場規模
韓国の急性期病院医療市場規模
台湾の急性期病院医療市場規模
...
-ヨーロッパ/中東/アフリカの急性期病院医療市場規模
イギリスの急性期病院医療市場規模
ドイツの急性期病院医療市場規模
フランスの急性期病院医療市場規模
ロシアの急性期病院医療市場規模
...
-その他地域の急性期病院医療市場規模
・競争状況
・企業情報

The Global Acute Hospital Care Market size was estimated at USD 246.47 billion in 2021 and expected to reach USD 265.74 billion in 2022, and is projected to grow at a CAGR 7.99% to reach USD 391.05 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Acute Hospital Care to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Medical Condition, the market was studied across Acute Care Surgery, Emergency Care, Short-Term Stabilization, and Trauma Care.

Based on Facility Type, the market was studied across General Acute Care Hospitals, Long Term Acute Care, Psychiatric Hospitals, Rehabilitation Hospitals, and Specialized Hospitals.

Based on Service, the market was studied across Coronary Care Unit, Intensive Care Unit, and Neonatal Intensive Care Unit.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Acute Hospital Care market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acute Hospital Care Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Acute Hospital Care Market, including 3M Company, Asklepios Kliniken GmbH & Co. KGaA, bioMérieux SA, CareCentrix, Inc., Community Health Systems, Inc., Emerus Holdings, Inc., Ernest Health, Inc., Fresenius Medical Care AG & Co, HCA Healthcare, Inc., IHH Healthcare Berhad, Legacy Lifepoint Health, Inc., McKesson Corporation, Mediclinic International PLC, Medline Industries, Inc., National HealthCare Corporation, PruittHealth Corporation, Ramsay Health Care Ltd, Tenet Healthcare Corporation, Universal Health Services, Inc., and Vibra Healthcare, LLC.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Acute Hospital Care Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acute Hospital Care Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acute Hospital Care Market?
4. What is the competitive strategic window for opportunities in the Global Acute Hospital Care Market?
5. What are the technology trends and regulatory frameworks in the Global Acute Hospital Care Market?
6. What is the market share of the leading vendors in the Global Acute Hospital Care Market?
7. What modes and strategic moves are considered suitable for entering the Global Acute Hospital Care Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing inpatient volume at hospitals for Acute Care
5.1.1.2. Increasing prevalence of chronic diseases
5.1.1.3. Availability of medicaid and medicare reimbursement
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals, facilities and equipment
5.1.3. Opportunities
5.1.3.1. Increasing number of hospital and unmet medical needs in emerging economies
5.1.4. Challenges
5.1.4.1. Dearth in infrastructure
5.2. Cumulative Impact of COVID-19

6. Acute Hospital Care Market, by Medical Condition
6.1. Introduction
6.2. Acute Care Surgery
6.3. Emergency Care
6.4. Short-Term Stabilization
6.5. Trauma Care

7. Acute Hospital Care Market, by Facility Type
7.1. Introduction
7.2. General Acute Care Hospitals
7.3. Long Term Acute Care
7.4. Psychiatric Hospitals
7.5. Rehabilitation Hospitals
7.6. Specialized Hospitals

8. Acute Hospital Care Market, by Service
8.1. Introduction
8.2. Coronary Care Unit
8.3. Intensive Care Unit
8.4. Neonatal Intensive Care Unit

9. Americas Acute Hospital Care Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Acute Hospital Care Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Acute Hospital Care Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Asklepios Kliniken GmbH & Co. KGaA
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. bioMérieux SA
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. CareCentrix, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Community Health Systems, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Emerus Holdings, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Ernest Health, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Fresenius Medical Care AG & Co
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. HCA Healthcare, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. IHH Healthcare Berhad
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Legacy Lifepoint Health, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. McKesson Corporation
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Mediclinic International PLC
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Medline Industries, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. National HealthCare Corporation
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. PruittHealth Corporation
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Ramsay Health Care Ltd
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Tenet Healthcare Corporation
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Universal Health Services, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Vibra Healthcare, LLC
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing